<DOC>
	<DOCNO>NCT01570153</DOCNO>
	<brief_summary>The purpose study evaluate ability non-invasive monitor measure much fluid body well various blood test ability predict worsen kidney function patient heart failure .</brief_summary>
	<brief_title>Biomonitoring Cardiorenal Syndrome Heart Failure ( BIONICS-HF ) Trial</brief_title>
	<detailed_description>Our specific aim : 1 . Evaluate individual collective ability pro-B type natriuretic peptide ( NT-pro-BNP ) , soluble ( ) ST2 , neutrophil gelatinase-associated lipocalin ( NGAL ) , bioelectrical impedance vector analysis ( BIVA ) predict in-hospital worsen renal function ( WRF ) patient evaluate emergency department ( ED ) acutely decompensated heart failure ( ADHF ) compare model clinical variable alone . 2 . Evaluate individual collective ability NT-proBNP , sST2 , NGAL , BIVA identify correct cause in-hospital WRF patient evaluate ED ADHF . 3 . Evaluate individual collective ability NT-pro-BNP , sST2 , NGAL , BIVA predict outcome ( all-cause death , all-cause re-hospitalization , initiation renal replacement therapy 180 day ) patient ADHF .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardio-Renal Syndrome</mesh_term>
	<criteria>Dyspnea think due ADHF NYHA class III IV symptoms renal failure require renal replacement therapy rior enrollment unable unwilling participate &gt; 6 hour first dose intravenous diuretic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>